検索結果 - Angela Meade
- 検索結果 1 - 12 結果 / 12
-
1
-
2
-
3
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial 著者: Michael Braun, Susan D. Richman, Philip Quirke, Catherine Daly, Julian Adlard, Faye Elliott, Jennifer H. Barrett, Peter Selby, Angela Meade, Richard Stephens, Mahesh Parmar, Michel Seymour
出版事項 2008Artigo -
4
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomise... 著者: Harpreet Wasan, Angela Meade, Richard Adams, Richard H. Wilson, Cheryl Pugh, David J. Fisher, Benjamin Sydes, Ayman Madi, Bruce Sizer, C. Lowdell, Gary Middleton, Rachel Butler, Richard Kaplan, Tim Maughan
出版事項 2014Artigo -
5
Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab 著者: Christopher G. Smith, David J. Fisher, Bart Claes, Tim Maughan, Shelley Idziaszczyk, Gilian Peuteman, Rebecca Harris, Michelle D. James, Angela Meade, Bharat Jasani, Richard Adams, Sarah Kenny, Richard Kaplan, Diether Lambrechts, Jeremy P. Cheadle
出版事項 2013Artigo -
6
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 M... 著者: Richard Adams, Angela Meade, Michel Seymour, Richard H. Wilson, Ayman Madi, David J. Fisher, Sarah Kenny, Edward Kay, Elizabeth Hodgkinson, Malcolm Pope, P. Rogers, Harpreet Wasan, Stephen Falk, Simon Gollins, Tamas Hickish, E.M. Bessell, David Propper, Megan Kennedy, Richard Kaplan, Tim Maughan
出版事項 2011Artigo -
7
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial 著者: Tim Maughan, Richard Adams, Christopher G. Smith, Angela Meade, Michel Seymour, Richard H. Wilson, Shelley Idziaszczyk, Rebecca Harris, David J. Fisher, Sarah Kenny, Edward Kay, Jenna Mitchell, Ayman Madi, Bharat Jasani, Michelle D. James, John Bridgewater, Megan Kennedy, Bart Claes, Diether Lambrechts, Richard Kaplan, Jeremy P. Cheadle
出版事項 2011Artigo -
8
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning 著者: Korsuk Sirinukunwattana, Enric Domingo, Susan D. Richman, Keara L. Redmond, Andrew Blake, Clare Verrill, Simon J. Leedham, Aikaterini Chatzipli, Claire Hardy, Celina Whalley, Chieh‐Hsi Wu, Andrew D. Beggs, Ultan McDermott, Philip D. Dunne, Angela Meade, Steven M. Walker, Graeme I. Murray, Leslie Samuel, Michel Seymour, Ian Tomlinson, Philip Quirke, Tim Maughan, Jens Rittscher, Viktor H. Koelzer
出版事項 2020Artigo -
9
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial 著者: Tim Eisen, Eleni Frangou, Bhavna Oza, A.W.S. Ritchie, Benjamin Smith, Richard Kaplan, Ian D. Davis, Martin R. Stockler, Laurence Albigès, Bernard Escudier, James Larkin, Axel Bex, Steven Joniau, Barry W. Hancock, Gregers G. Hermann, Joaquim Bellmunt, Elizabeth Hodgkinson, Grant D. Stewart, Jim Barber, Janet E. Brown, R. McMenemin, Paul Nathan, Lisa Pickering, Mahesh Parmar, Angela Meade
出版事項 2020Artigo -
10
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer 著者: Marc Henrion, Matthew Frampton, Ghislaine Scélo, Mark P. Purdue, Yuanqing Ye, Peter Broderick, A.W.S. Ritchie, Richard Kaplan, Angela Meade, James McKay, Mattias Johansson, Mark Lathrop, James Larkin, Nathaniel Rothman, Zhaoming Wang, Wong‐Ho Chow, Victoria L. Stevens, W. Ryan Diver, Susan M. Gapstur, Demetrius Albanes, Jarmo Virtamo, Xifeng Wu, Paul Brennan, Stephen J. Chanock, Timothy Eisen, Richard S. Houlston
出版事項 2012Revisão -
11
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of rela... 著者: Bhavna Oza, Eleni Frangou, Ben Smith, Hanna Bryant, Richard Kaplan, Babak Choodari‐Oskooei, Tom Powles, Grant D. Stewart, Laurence Albigès, Axel Bex, Toni K. Choueiri, Ian D. Davis, Tim Eisen, Alison Fielding, David J. Harrison, Anita McWhirter, Salena Mulhere, Paul Nathan, Brian I. Rini, A.W.S. Ritchie, Sarah Scovell, Clare Shakeshaft, Martin R. Stockler, Nat Thorogood, Mahesh Parmar, James Larkin, Angela Meade
出版事項 2021Artigo -
12
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 著者: Nalinie Joharatnam‐Hogan, Duaa Hatem, Fay Cafferty, Giovanna Petrucci, David Cameron, Alistair Ring, Howard Kynaston, Duncan C. Gilbert, Richard H. Wilson, Richard Hubner, Daniel Swinson, Siobhan Cleary, Alexander J. Robbins, Mairead MacKenzie, Martin Scott-Brown, Sharmila Sothi, L. Dawson, Lisa Capaldi, Mark Churn, David Cunningham, Vincent Khoo, Anne Armstrong, Nicola Ainsworth, Gail Horan, Duncan Wheatley, Russell Mullen, F. Lofts, Axel Walther, Rebecca Herbertson, John D. Eaton, Ann O’Callaghan, Andrew Eichholz, M. Kagzi, Daniel Patterson, Krishna Narahari, Jennifer Bradbury, Zuzana Stokes, Azhar Rizvi, G.A. Walker, Victoria Kunene, Narayanan Srihari, Aleksandra Gentry‐Maharaj, Angela Meade, Carlo Patrono, Bianca Rocca, Ruth E. Langley
出版事項 2023Artigo
関連主題
Internal medicine
Medicine
Cancer
Oncology
Colorectal cancer
Chemotherapy
Oxaliplatin
Surgery
Cetuximab
Confidence interval
Hazard ratio
Biology
Environmental health
Gene
Population
Randomized controlled trial
Capecitabine
Clinical trial
Fluorouracil
Folinic acid
Genetics
KRAS
Pathology
Receptor
Renal cell carcinoma
(+)-Naloxone
Adjuvant
Alternative medicine
Anesthesia
Artificial intelligence